| Literature DB >> 28982336 |
Zhen-Feng Chen1, Chris Orvig2, Hong Liang1.
Abstract
There has been a growing interest in the rational design of multi-targeted drugs with the aim of enhancing overall efficacy and/or improving safety. The development of multi-targeted drugs might yield new avenues in the treatment of cancers that involve multiple pathogenic factors. In this review, we focus on the multi-targeted metal-based anticancer agents, which include platinum, ruthenium, rhodium, gold, silver, copper, cobalt, zinc, and nickel complexes. Future directions for the development of multi-targeted metal-based anticancer agents are also proposed. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Multi-target; anticancer agents; cytotoxicity; metal complexes; nickel complexes; pathogenic factors.
Mesh:
Substances:
Year: 2017 PMID: 28982336 DOI: 10.2174/1568026617666171004155437
Source DB: PubMed Journal: Curr Top Med Chem ISSN: 1568-0266 Impact factor: 3.295